Acogenib 250mg Tablet
Marketer
Accord Pharmaceuticals
Salt Composition
Gefitinib (250mg)
Overview Acogenib 250mg Tablet
Acogenib 250mg tablets treat metastatic non-small cell lung cancer in patients with abnormal epidermal growth factor receptor (EGFR) genes and no prior cancer therapy. Dosage is determined by your physician, and treatment duration depends on individual response. Regular liver function monitoring may be recommended. Common adverse reactions include nausea, diarrhea, dry skin, and appetite loss. Increased fluid intake may mitigate some side effects. Report any persistent or worsening side effects, particularly oral ulceration, visual disturbances, or respiratory difficulties. Women should employ effective contraception throughout treatment and for one month afterward to prevent pregnancy. Always inform your doctor of all other medications you are currently using.
Primary Ingredients of Acogenib 250mg Tablet
No text was provided. Please provide the text you would like me to rephrase.
Uses of Acogenib 250mg Tablet
Lung cancer (excluding small cell types)
Major Benefits of Acogenib 250mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 250mg Acogenib tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
Common Side effects of Acogenib 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Acogenib 250mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Acogenib 250mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Acogenib 250mg Tablet works:
Acogenib 250mg tablets are used in cancer treatment. Their mechanism involves inhibiting the activity of a faulty protein responsible for stimulating cancer cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Acogenib 250mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Use of Acogenib 250mg tablets is contraindicated during pregnancy due to established risk to the fetus. Nevertheless, in exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
The use of Acogenib 250mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 250mg Acogenib tablet may impair driving ability due to potential adverse effects.
KidneyCAUTION
Patients with severe kidney impairment should use Acogenib 250mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Acogenib 250mg tablets appear to pose minimal risk for individuals with hepatic impairment. Preliminary findings indicate dose modification may be unnecessary in this population. Physician consultation is advised.
What if you forget to take Acogenib 250mg Tablet :
Omit any missed Acogenib 250mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Acogenib 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently